Table 1.
Characteristics of Patients Participating in PALM Registry Survey Risk Questions
| Non-Responder
Characteristics N=858 |
P-value* | Overall Responder
Characteristics N=2708 |
Text Only (N=757) |
Bar Graph (N=1164) |
Pictogram (N=787) |
|
|---|---|---|---|---|---|---|
| Age, y (median, IQR) | 69.0 (61.0–76.0) | <.0001 | 67 (59.0–74.0) | 67 (59.0–74.0) | 67 (59.0–74.0) | 67 (59.0–75.0) |
| Numeracy score (median, IQR) | 15.0 (9.3–20.0) | <.0001 | 17 (12.0–21.0) | 16 (12.0–21.0) | 17 (12.0–21.0) | 16 (12.0–21.0) |
| Prior ASCVD | 385 (44.9%) | 0.5217 | 1249 (46.1%) | 348 (46.0%) | 548 (47.1%) | 353 (44.9%) |
| Male sex | 440 (51.3%) | 0.0530 | 1491 (55.1%) | 424 (56.0%) | 651 (55.9%) | 416 (52.9%) |
| Race | <.0001 | |||||
| White | 694 (80.9%) | 2366 (87.4%) | 664 (87.7%) | 1020 (87.6%) | 682 (86.7%) | |
| Black | 138 (16.1%) | 280 (10.3%) | 73 (9.6%) | 120 (10.3%) | 87 (11.1%) | |
| Other/unknown | 26 (3.0%) | 62 (2.3%) | 20 (2.6%) | 24 (2.1%) | 18 (2.3%) | |
| Education | <.0001 | |||||
| Below college | 326 (38.0%) | 922 (34.0%) | 254 (33.6%) | 379 (32.6%) | 289 (36.7%) | |
| College or above | 508 (59.2%) | 1760 (65.0%) | 493 (65.1%) | 778 (66.8%) | 489 (62.1%) | |
| Missing | 24 (2.8%) | 26 (1.0%) | 10 (1.3%) | 7 (0.6%) | 9 (1.1%) | |
| Income | 0.0927 | |||||
| <35,000 | 219 (25.5%) | 620 (22.9%) | 178 (23.5%) | 260 (22.3%) | 182 (23.1%) | |
| 35,000–75,000 | 207 (24.1%) | 607 (22.4%) | 156 (20.6%) | 268 (23.0%) | 183 (23.3%) | |
| 75,000–100,000 | 54 (6.3%) | 229 (8.5%) | 59 (7.8%) | 108 (9.3%) | 62 (7.9%) | |
| ≥100,000 | 107 (12.5%) | 383 (14.1%) | 111 (14.7%) | 177 (15.2%) | 95 (12.1%) | |
| Missing/refused/don’t know | 271 (31.6%) | 869 (32.1%) | 253 (33.4%) | 351 (30.2%) | 265 (33.7%) | |
| Insurance | 0.0077 | |||||
| Private | 498 (58.0%) | 1715 (63.3%) | 478 (63.1%) | 748 (64.3%) | 489 (62.1%) | |
| Medicare | 279 (32.5%) | 758 (28.0%) | 218 (28.8%) | 318 (27.3%) | 222 (28.2%) | |
| Medicaid | 26 (3.0%) | 92 (3.4%) | 18 (2.4%) | 37 (3.2%) | 37 (4.7%) | |
| No insurance | 14 (1.6%) | 56 (2.1%) | 16 (2.1%) | 25 (2.1%) | 15 (1.9%) | |
| Others | 21 (2.4%) | 57 (2.1%) | 16 (2.1%) | 29 (2.5%) | 12 (1.5%) | |
| Missing | 20 (2.3%) | 30 (1.1%) | 11 (1.5%) | 7 (0.6%) | 12 (1.5%) | |
| Clinic type | 0.0047 | |||||
| Cardiology | 263 (30.7%) | 996 (36.8%) | 276 (36.5%) | 462 (39.7%) | 258 (32.8%) | |
| Primary care | 376 (43.8%) | 1075 (39.7%) | 300 (39.6%) | 445 (38.2%) | 330 (41.9%) | |
| Other | 219 (25.5%) | 637 (23.5%) | 181 (23.9%) | 257 (22.1%) | 199 (25.3%) | |
| Aspirin use | 412 (48.0%) | 0.0443 | 1407 (52.0%) | 382 (50.5%) | 631 (54.2%) | 394 (50.1%) |
| Statin use | 600 (69.9%) | 0.0242 | 2000 (73.9%) | 543 (71.7%) | 887 (76.2%) | 570 (72.4%) |
| BP medication use | 670 (78.1%) | 0.3293 | 2071 (76.5%) | 585 (77.3%) | 893 (76.7%) | 593 (75.3%) |
*
P-value comparing responders to nonresponders
Data are n (%) except where indicated.
ASCVD, atherosclerotic cardiovascular disease; BP, blood pressure; PALM, Patient and Provider Assessment of Lipid Management.